6/3/11 Contest Update
Apparently, all those three-day weekend BBQs left investors with indigestion and little appetite to scarf up stocks. But biotechs did fare better than the broad market, as they have YTD.
At Friday’s close, the Nasdaq Biotech Index was up 14.34% YTD (vs. up 15.71% YTD a week ago) and the Contest median was up 11.39% YTD (vs. up 13.64% YTD a week ago). The Nasdaq Composite Index was up 3.01% YTD (vs. up 5.43% YTD a week ago).
First place MCBIO’s portfolio (up 51.72% YTD) managed to buck the down market scoring another weekly gain, with CRAZYP’s portfolio (up 37.46% YTD) and ROCKY’s portfolio (up 29.99% YTD) holding on to second and third place..
At Friday's close, 32 of the 38 Contest portfolios were in the black with 14 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Enjoy the weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
6/3/11
Rank Name Profit/Loss
1 MCBIO 51,722
2 CRAZYP 37,456
3 ROCKY 29,991
4 RRGE 28,715
5 FIB 26,541
6 IJF 25,275
7 GENE 24,993
8 GHMM 24,040
9 RKRW 21,997
10 IMAN 19,537
Week's Top 5 Gainers
Symbol 5/27 6/3 % change
AFFX 5.99 7.25 21.04%
GNOM 14.33 17.11 19.40%
BNVI 0.62 0.72 16.07%
LXRX 1.44 1.66 15.28%
BDSI 3.28 3.62 10.37%
Week's Top 5 Losers
Symbol 5/27 6/3 % change
CBPO 16.10 10.35 -35.71%
OREX 2.86 2.12 -25.87%
OCLS 2.14 1.82 -15.02%
MYG.TO 0.43 0.38 -12.79%
MITI 6.49 5.69 -12.33% |
